Radiation therapy in the management of locally advanced prostate cancer.

Current Urology Reports
Jeff M Michalski

Abstract

Locally advanced prostate cancer generally refers to those patients with clinical stages T3-4 disease. Patients with locally advanced cancer frequently are included in clinical trials that examine treatment for patients at high risk for relapse based on presenting prostate-specific antigen, high Gleason score, or advanced clinical stage. There is a growing body of evidence that suggests that men with localized prostate cancer benefit from high-dose radiation therapy delivered with three-dimensional conformal radiation therapy, intensity-modulated radiation therapy, or proton beam therapy. Most importantly, neoadjuvant and adjuvant androgen-deprivation therapy have significantly improved outcomes in men with locally advanced or high-risk prostate cancer. Although questions remain regarding the optimal timing and duration of adjuvant hormonal therapy, a combination of long-term androgen deprivation started before radiation therapy and continued for 2 years represents a North American standard of care for this patient population.

References

Jan 1, 1990·International Journal of Radiation Oncology, Biology, Physics·W G SmitB H van der Werf-Messing
Dec 1, 1988·International Journal of Radiation Oncology, Biology, Physics·G E HanksJ J Diamond
May 1, 1980·International Journal of Radiation Oncology, Biology, Physics·C A PerezW Bauer
Jul 4, 1998·International Journal of Radiation Oncology, Biology, Physics·M J ZelefskyZ Fuks
Mar 31, 1999·International Journal of Radiation Oncology, Biology, Physics·P C KoperP C Levendag
Feb 8, 2000·International Journal of Radiation Oncology, Biology, Physics·J M MichalskiJ D Cox
Jul 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R ValicentiD Grignon
Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·Alan PollackIsaac Rosen
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·Janice K RyuJames D Cox
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M RoachUNKNOWN Radiation Therapy Oncology Group 9413
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerald E HanksUNKNOWN Radiation Therapy Oncology Group
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Jeff M MichalskiJames D Cox
Nov 3, 2004·International Journal of Radiation Oncology, Biology, Physics·Véronique BeckendorfPierre Bey
Mar 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Stephanie T H PeetersPeter C M Koper
Apr 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Miljenko V PilepichDavid Grignon
Jun 2, 2005·British Journal of Cancer·D P DearnaleyUNKNOWN MRC Testicular Tumour Working Party
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Jeff M MichalskiJames D Cox

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.